Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru 30-minute medicine delivery with digital health records and chronic care management; YC W20 $3.1M at ₹10.7Cr revenue with 36% CAGR competing with PharmEasy and 1mg for India pharmacy delivery.
Farmako Healthcare is a Bengaluru-based healthtech platform — backed by Y Combinator (W20) and HOF Capital with $3.1 million raised including a $1.6 million round in August 2024 and a pre-Series A in June 2025 — providing ultra-fast medicine delivery (30-minute delivery within service areas), digital health records management, and personalized health insights for patients managing chronic conditions and routine pharmacy needs in Indian metros. Founded in 2019 and generating ₹10.7 crore (approximately $1.3 million USD) in annual revenue as of March 2024 with 36% revenue CAGR and a 63-person team, Farmako serves the medication adherence and pharmacy access market in India's urban health ecosystem.
Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.
Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.